Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Jan 2008

Poirier Judes

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Alzheimer's disease research and treatments
Share to Apolipoproteins E
Share to Brain

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholinesterase and Neurodegenerative Diseases

Share to Clinical Trials as Topic

Share to Genetic Predisposition to Disease

Share to Genetic Therapy

Source

Identifiers

PMID: 18632009
DOI: 10.1016/j.jalz.2007.11.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.PMID 18632009Read ↗

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategiesSemantic proximity Read ↗

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapySemantic proximity Read ↗

Apolipoprotein E as a Target for Developing New Therapeutics for Alzheimer's Disease Based on Studies From Protein, RNA, and Regulatory Region of the GeneSemantic proximity Read ↗

A review of the advances, insights, and prospects of gene therapy for Alzheimer’s disease: A novel target for therapeutic medicineSemantic proximity Read ↗

APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's.Semantic proximity Read ↗

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E in Alzheimer’s Disease: Focus on Synaptic Function and Therapeutic StrategySemantic proximity Read ↗

Gene Therapy Strategies for Alzheimer's Disease: An OverviewSemantic proximity Read ↗

The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.Semantic proximity Read ↗

The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal modelsSemantic proximity Read ↗

Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysisSemantic proximity Read ↗

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.